Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InspireMD, Inc.NSPR · Entity 7318 | Director | May 06, 2026 | May 08, 2026 |
| MERIT MEDICAL SYSTEMS INCMMSI · Entity 3858 | Director | May 18, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InspireMD, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 237,096 |
Ending reported balance
After 2026-05-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Purchase · Acquired 15,995 · Balance 163,841 F1: The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.13 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 2 · 2026-05-07 · Purchase · Acquired 73,255 · Balance 237,096 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.13 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
MERIT MEDICAL SYSTEMS INC
Report date May 18, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, No Par ValueSEC Table I · non-derivative | Direct | 3,457 |
Reported balance
After 2026-05-18 transaction · row 1
1 source rowRow 1 · 2026-05-18 · Grant · Acquired 3,457 · Balance 3,457 F1: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cardiovascular Systems Inc
Report date April 27, 2023 · Filed April 27, 2023
Section 16 reporting ended · disclosed 2023-04-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-04-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-04-27 · Disposition to issuer · Disposed 578,310 · Balance 232,712 F1: Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of unvested restricted stock became fully vested immediately prior to the effective time of the merger. Shares of restricted stock were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. Row 2 · 2023-04-27 · Disposition to issuer · Disposed 232,712 · Balance 0 F2: Converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-04-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-04-27 · Disposition to issuer · Disposed 34,297 · Balance 0 F3: Pursuant to the Merger Agreement, each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of unvested restricted stock became fully vested immediately prior to the effective time of the merger. Shares of restricted stock were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes.
F2: Converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes.
F3: Pursuant to the Merger Agreement, each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 19, 2026 22:12 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 3,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001174531-26-000004 · form4-05192026_100534.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,457 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 07, 2026 Filed May 8, 2026 21:08 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 73,255 | $1.15 | $84,243.25 |
DisclosureSEC source: 0001493152-26-022020 · ownership.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,096 Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:08 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 15,995 | $1.15 | $18,394.25 |
DisclosureSEC source: 0001493152-26-022020 · ownership.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,841 F1 · price: The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.13 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 23:12 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 88,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-002671 · ownership.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,846 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 7,418 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001735 · ownership.xml · derivative · entry 2 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,065 Underlying: Common Stock · 7,418 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 16,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001735 · ownership.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,793 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| April 27, 2023 Filed Apr 27, 2023 20:32 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Disposition to issuerRestricted Stock Units · Derivative | 34,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009593 · form4.xml · derivative · entry 3 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,297 shares Expires not disclosed F3 · derivative.exercise_price: Pursuant to the Merger Agreement, each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. Read SEC document |
| April 27, 2023 Filed Apr 27, 2023 20:32 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Disposition to issuerCommon Stock | 232,712 | $20.00 | $4,654,240.00 |
DisclosureSEC source: 0001062993-23-009593 · form4.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · shares: Converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes. Read SEC document |
| April 27, 2023 Filed Apr 27, 2023 20:32 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Disposition to issuerCommon Stock | 578,310 | $20.00 | $11,566,200.00 |
DisclosureSEC source: 0001062993-23-009593 · form4.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,712 F1 · shares: Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of unvested restricted stock became fully vested immediately prior to the effective time of the merger. Shares of restricted stock were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. Read SEC document |
| February 13, 2023 Filed Feb 14, 2023 21:44 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 5,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-003440 · form4.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 811,022 F2 · shares: Restrictions lapse as to 2,539 shares on 2/14/24 and as to 2,538 shares on 2/14/25. Read SEC document |
| February 12, 2023 Filed Feb 14, 2023 21:44 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 1,493 | $19.70 | $29,412.10 |
DisclosureSEC source: 0001062993-23-003440 · form4.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 805,945 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of prior restricted stock grants by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grants. Read SEC document |
| August 18, 2022 Filed Aug 23, 2022 20:11 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Disposition to issuerCommon Stock | 77,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021197 · rdgdoc.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,438 F1 · shares: Represents shares of performance-based restricted stock granted in August 2019 that have been forfeited based on the Company's three year total shareholder return for fiscal years 2020, 2021 and 2022 versus the Company's peer group. Read SEC document |
| August 12, 2022 Filed Aug 17, 2022 00:56 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 16,006 | $16.64 | $266,339.84 |
DisclosureSEC source: 0001437749-22-020769 · rdgdoc.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884,466 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of prior restricted stock grants by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grants. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:24 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 239,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-019621 · rdgdoc.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,472 F2 · shares: Subject to performance-based forfeiture of 119,910 shares based on the Company's three-year total shareholder return for fiscal years 2023, 2024 and 2025 versus the Company's peer group, and for 119,909 shares based on the Company's average annual revenue growth in fiscal years 2023, 2024 and 2025. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:24 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 79,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-019621 · rdgdoc.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 660,653 F1 · shares: Restrictions lapse as to 26,647 shares on each of 8/13/23 and 8/13/24 and as to 26,646 shares on 8/13/25. Read SEC document |
| May 20, 2022 Filed May 23, 2022 20:10 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | PurchaseCommon Stock | 3,000 | $14.49 | $43,466.70 |
DisclosureSEC source: 0001437749-22-013310 · rdgdoc.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,713 Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 21:15 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 5,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-002873 · rdgdoc.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,713 F2 · shares: Restrictions lapse as to 2,739 shares on 2/12/23 and as to 2,738 shares on 2/12/24. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:15 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | PurchaseCommon Stock | 2,500 | $18.52 | $46,293.00 |
DisclosureSEC source: 0001437749-22-002873 · rdgdoc.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,236 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.50 to $18.58 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 28, 2021 Filed Aug 31, 2021 23:35 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 4,593 | $35.38 | $162,500.34 |
DisclosureSEC source: 0000914190-21-000318 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,736 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 22:57 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 27,637 | $36.18 | $999,906.66 |
DisclosureSEC source: 0000914190-21-000303 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,329 F2 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 22:57 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Disposition to issuerCommon Stock | 27,842 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-21-000303 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,966 F1 · shares: Represents shares of performance-based restricted stock granted in August 2018 that have been forfeited based on the Company's three year total shareholder return for fiscal years 2019, 2020 and 2021 versus the Company's peer group. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:42 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 10,570 | $36.07 | $381,259.90 |
DisclosureSEC source: 0000914190-21-000265 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,808 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of prior restricted stock grants by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grants. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 23:12 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 99,422 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-21-000235 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,378 F2 · shares: Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2022, 2023 and 2024 versus the Company's peer group. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 23:12 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 33,141 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-21-000235 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,956 F1 · shares: Restrictions lapse as to 11,047 shares on each of 8/13/22, 8/13/23 and 8/13/24. Read SEC document |
| May 10, 2021 Filed May 11, 2021 12:03 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | PurchaseCommon Stock | 1,000 | $34.41 | $34,410.00 |
DisclosureSEC source: 0000914190-21-000143 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,815 Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 20:48 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 4,593 | $32.62 | $149,823.66 |
DisclosureSEC source: 0000914190-20-000368 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,815 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 21:29 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 32,676 | $32.77 | $1,070,792.52 |
DisclosureSEC source: 0000914190-20-000342 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,408 F2 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 21:29 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Disposition to issuerCommon Stock | 27,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-20-000342 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,084 F1 · shares: Represents shares of performance-based restricted stock granted in August 2017 that have been forfeited based on the Company's three year total shareholder return for fiscal years 2018, 2019 and 2020 versus the Company's peer group. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:56 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 9,366 | $31.11 | $291,376.26 |
DisclosureSEC source: 0000914190-20-000316 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,966 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Issuer to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 15:30 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | PurchaseCommon Stock | 1,000 | $32.19 | $32,187.00 |
DisclosureSEC source: 0000914190-20-000303 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,332 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.185 to $32.1899 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:38 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 116,298 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-20-000275 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,332 F2 · shares: Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2021, 2022 and 2023 versus the Company's peer group. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:38 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 38,766 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-20-000275 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,034 F1 · shares: Restrictions lapse as to 12,922 shares on each of 8/13/21, 8/13/22 and 8/13/23. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 20:11 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 4,257 | $50.14 | $213,445.98 |
DisclosureSEC source: 0000914190-19-000354 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,268 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Issuer to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:15 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 52,013 | $48.22 | $2,508,066.86 |
DisclosureSEC source: 0000914190-19-000341 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,525 F2 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:15 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Disposition to issuerCommon Stock | 4,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-19-000341 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,538 F1 · shares: Represents shares of performance-based restricted stock granted in August 2016 that have been forfeited based on the Company's three year total shareholder return for fiscal years 2017, 2018 and 2019 versus the Company's peer group. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:45 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 6,794 | $47.58 | $323,258.52 |
DisclosureSEC source: 0000914190-19-000310 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,290 F1 · shares: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Issuer to withhold shares otherwise issuable upon vesting of the previously reported grant. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 21:08 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 77,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-19-000278 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,084 F2 · shares: Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2020, 2021 and 2022 versus the Company's peer group. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 21:08 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 25,676 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-19-000278 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,056 F1 · shares: Restrictions lapse as to 8,559 shares on each of 8/13/20 and 8/13/21 and as to 8,558 shares on 8/13/22. Read SEC document |
| August 29, 2018 Filed Aug 29, 2018 20:11 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | PurchaseCommon Stock | 2,500 | $38.39 | $95,971.50 |
DisclosureSEC source: 0000914190-18-000354 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,362 Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 20:22 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 84,013 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-18-000366 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,380 F2 · shares: Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2019, 2020 and 2021 versus the Company's peer group. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 20:22 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 28,005 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-18-000366 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,367 F1 · shares: Restrictions lapse as to 9,335 shares on each of 8/28/19, 8/28/20 and 8/28/21. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:09 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | Tax withholdingCommon Stock | 6,674 | $37.24 | $248,539.76 |
DisclosureSEC source: 0000914190-18-000336 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,862 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 20:13 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | SaleCommon Stock | 5,529 | $30.41 | $168,133.57 |
DisclosureSEC source: 0000914190-17-000254 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,536 F1 · shares: In connection with the vesting and delivery of restricted stock, on the date the shares were sold the net proceeds were used to pay required withholding taxes. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $30.52 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 20:34 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 94,295 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-17-000218 · edgar.xml · nonDerivative · entry 2 Ward Scott R. · CIK 0001174531 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,065 F2 · shares: Subject to performance-based forfeiture based on the three year total shareholder return for fiscal years 2018, 2019 and 2020 versus the Company's peer group. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 20:34 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantCommon Stock | 31,432 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-17-000218 · edgar.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,770 F1 · shares: Restrictions lapse as to 10,478 shares on 8/13/18 and 10,477 shares on each of 8/13/19 and 8/13/20. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.